NCT01613092View on ClinicalTrials.gov

Prevention of Arrhythmia Device Infection Trial (PADIT)

PHASE4CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions
Arrhythmia
Interventions
DRUG

Incremental

Cefazolin and Vancomycin pre-op, bacitracin wash and postoperative cefalexin or clindamycin

DRUG

Cefazolin

Preoperative antibiotic

Trial Locations (2)

L8L 2X2

Hamilton General Hospital, McMaster University, Hamilton

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

Sponsors
All Listed Sponsors
lead

Population Health Research Institute

OTHER

NCT01613092 - Prevention of Arrhythmia Device Infection Trial (PADIT) | Biotech Hunter | Biotech Hunter